Investment Analysts’ Recent Ratings Changes for Danaher (DHR)

Danaher (NYSE: DHR) recently received a number of ratings updates from brokerages and research firms:

• 7/24/2024 – Danaher had its price target raised by analysts at Robert W. Baird from $271.00 to $278.00. They now have an “outperform” rating on the stock.
• 7/24/2024 – Danaher had its price target raised by analysts at Royal Bank of Canada from $297.00 to $300.00. They now have an “outperform” rating on the stock.
• 7/24/2024 – Danaher had its price target raised by analysts at SVB Leerink LLC from $275.00 to $280.00. They now have an “outperform” rating on the stock.
• 7/24/2024 – Danaher had its price target raised by analysts at The Goldman Sachs Group, Inc. from $225.00 to $250.00. They now have a “neutral” rating on the stock.
• 7/24/2024 – Danaher had its price target raised by analysts at Bank of America Co. from $270.00 to $275.00. They now have a “neutral” rating on the stock.
• 7/24/2024 – Danaher had its price target raised by analysts at Stifel Nicolaus from $235.00 to $250.00. They now have a “hold” rating on the stock.
• 7/24/2024 – Danaher had its price target raised by analysts at Barclays PLC from $270.00 to $285.00. They now have an “equal weight” rating on the stock.
• 7/24/2024 – Danaher had its price target raised by analysts at TD Cowen from $290.00 to $310.00. They now have a “buy” rating on the stock.
• 7/2/2024 – Danaher had its price target lowered by analysts at Evercore ISI from $266.00 to $260.00. They now have an “outperform” rating on the stock.
• 6/25/2024 – Danaher was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 6/17/2024 – Danaher was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 6/3/2024 – Danaher is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $295.00 price target on the stock.

Danaher Price Performance

Danaher stock traded up $3.54 on Tuesday, reaching $275.19. The company’s stock had a trading volume of 2,953,156 shares, compared to its average volume of 2,917,059. The business’s fifty day moving average price is $255.25 and its 200 day moving average price is $249.66. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.04 and a current ratio of 1.43. The company has a market cap of $198.74 billion, a price-to-earnings ratio of 46.64, a PEG ratio of 4.24 and a beta of 0.84. Danaher Co. has a twelve month low of $182.09 and a twelve month high of $277.72.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.15. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period last year, the company earned $2.05 EPS. Equities analysts expect that Danaher Co. will post 7.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 26th. Stockholders of record on Friday, June 28th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date of this dividend was Friday, June 28th. Danaher’s dividend payout ratio (DPR) is currently 18.31%.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 9,600 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $5,566,486.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, SVP Brian W. Ellis sold 9,600 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $5,566,486.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Alan G. Spoon sold 708 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the sale, the director now directly owns 116,202 shares in the company, valued at approximately $28,304,483.16. The disclosure for this sale can be found here. Insiders have sold 84,775 shares of company stock worth $21,802,690 in the last three months. Insiders own 11.10% of the company’s stock.

Institutional Trading of Danaher

Several hedge funds and other institutional investors have recently modified their holdings of DHR. Argus Investors Counsel Inc. boosted its stake in shares of Danaher by 4.2% during the 4th quarter. Argus Investors Counsel Inc. now owns 2,925 shares of the conglomerate’s stock worth $677,000 after buying an additional 119 shares during the last quarter. Mayflower Financial Advisors LLC raised its holdings in Danaher by 31.0% in the 4th quarter. Mayflower Financial Advisors LLC now owns 1,987 shares of the conglomerate’s stock valued at $460,000 after acquiring an additional 470 shares during the period. Chicago Capital LLC lifted its position in Danaher by 16.5% during the fourth quarter. Chicago Capital LLC now owns 4,233 shares of the conglomerate’s stock worth $979,000 after acquiring an additional 600 shares during the last quarter. Pallas Capital Advisors LLC boosted its holdings in shares of Danaher by 180.5% during the fourth quarter. Pallas Capital Advisors LLC now owns 8,753 shares of the conglomerate’s stock worth $2,025,000 after acquiring an additional 5,633 shares during the period. Finally, SevenBridge Financial Group LLC grew its position in shares of Danaher by 5.1% in the fourth quarter. SevenBridge Financial Group LLC now owns 1,558 shares of the conglomerate’s stock valued at $360,000 after purchasing an additional 75 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.